Bioregenx (BRGX) Long-Term Deferred Tax (2023 - 2025)
Bioregenx's (BRGX) quarterly Long-Term Deferred Tax came in at $1.4 million in Q4 2025, up 98.02% quarter-over-quarter from $707000.0 in Q4 2023.
Bioregenx (BRGX) Long-Term Deferred Tax (2023 - 2025) Analysis & Trends
Bioregenx's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.4 million, changed N/A from the prior year.
- Long-Term Deferred Tax rose to $1.4 million in Q4 2025 per BRGX's latest filing, from $707000.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $1.4 million in Q4 2025 and bottomed at $707000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 32.02 Bn | 24.70 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.71 Bn | 13.81 Bn | 482.22 Mn |
| 3 | Healthequity | 8.37 Bn | 8.10 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.92 Bn | 5.61 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.92 Bn | 5.38 Bn | 106.18 Mn |
| 6 | MiniMed | 4.50 Bn | 4.21 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.42 Bn | 4.36 Bn | 216.84 Mn |
| 8 | Doximity | 3.94 Bn | 3.19 Bn | 125.97 Mn |
| 9 | Privia Health | 3.11 Bn | 2.69 Bn | - |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2023 | 707,000.00 |